ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol: |
Name of Each Exchange on Which Registered: | ||
one-half of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
3 | ||||
4 | ||||
4 | ||||
22 | ||||
52 | ||||
52 | ||||
52 | ||||
52 | ||||
53 | ||||
53 | ||||
53 | ||||
53 | ||||
56 | ||||
56 | ||||
57 | ||||
57 | ||||
58 | ||||
59 | ||||
59 | ||||
67 | ||||
67 | ||||
70 | ||||
71 | ||||
73 | ||||
73 | ||||
73 |
• | our being a company with no operating history and no revenue; |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of a prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the continued uncertainty resulting from the COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential investment opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; |
• | our financial performance following our initial public offering; or |
• | the other risks and uncertainties discussed in “Risk Factors” and elsewhere in this Report. |
• | seeking sustainable growth of portfolio assets and ultimately long-term value creation through consistent and disciplined implementation of environmental, social and governance principles and sustainable business practices; |
• | being long-term and engaged shareholders; |
• | promoting a constructive and collaborative approach focused on all stakeholders; |
• | partnering with families and founders to facilitate effective business practices while recognizing that confrontational engagement may be ineffective in the European business environment; |
• | providing long-term and committed capital to accelerate beneficial change; and |
• | adopting a customized approach utilizing varied levers to achieve their aims depending on the specific situation. |
• | deep operating and industrial understanding of several sectors; |
• | financial strength and long-term capital; |
• | strong focus on high standards of corporate governance; |
• | entrepreneurial heritage and rapid decision-making supported by a robust operations team; and |
• | a track-record of mergers and acquisitions, complex financial transactions and capital markets transactions. |
• | a significant shareholder in adidas AG; |
• | a significant shareholder in Arkema S.A., a French listed specialty chemicals business; |
• | the largest shareholder in OCI N.V., a leading fertilizer and chemicals company listed on the Amsterdam stock exchange; |
• | the largest shareholder in Orascom Construction PLC, a leading engineering, procurement and construction contractor listed on Nasdaq Dubai and on the Egyptian Stock Exchange; and |
• | a significant shareholder in Signature Aviation PLC, a U.K. listed air transportation services provider with a focus on the business jet and private aircraft market. |
• | the co-ownership alongside another prominent U.S. based investor of Aston Villa Football Club, the largest professional soccer club of Birmingham, the second largest city in England; |
• | being a significant shareholder in Babylon Health (Babylon Holdings Ltd.), a technology and artificial intelligence for healthcare start-up company, valued in excess of $2 billion as of August 2019; and |
• | being a significant shareholder alongside other like-minded institutions in the 2019 landmark real estate transaction pursuant to which they jointly acquired a 48.5% interest of a joint venture investment vehicle with Vornado, which owns an upper Fifth Avenue and Times Square, New York City, retail real estate portfolio valued by the transaction at $5.56 billion. |
• | the appointment of a talented chief executive officer to succeed the incumbent chief executive officer, who had headed the firm for 15 years, ensuring a smooth transition; |
• | the exit from the golf business (sale of TaylorMade and other golf brands, including Adams Golf and Ashworth) and the divestment of non-core footwear brands such as Rockport; |
• | since 2016, adidas dividend per share has increased from €2.0 per share to €3.35 per share for 2018. This was announced to be €3.85 per share for 2019, but it was canceled due to COVID-19; |
• | initiatives to raise operating margins from 6.5% in 2015 to 11.3% in 2019; |
• | in 2018, adidas initiated a €3 billion buyback program of which approximately €1.8 billion has already been executed through to the end of 2019; |
• | an increased focus on research & development, and the development of new environmentally friendly and high-tech products as illustrated by the launch of Primeblue, a high-performance material made in part with recycled Parley Ocean Plastic, or Futurecraft, a shoe made with liquid resin elastomers produced by Arkema; and |
• | an enhancement of the international profile and global perspectives of the company. |
• | operating companies, setting and changing strategies, and identifying, monitoring and recruiting world-class talent; |
• | developing and growing companies organically by expanding their product range and geographic footprint; |
• | acquiring companies, leading transformational transactions or corporate restructurings and managing corporate integration with success; |
• | investing in equity and fixed income assets in both public and private markets across various sectors, jurisdictions and economic cycles; and |
• | developing and maintaining extensive relationships with owners and operators of companies, but also with a wide range of financial and legal advisers. |
• | our team’s relationships with numerous operating companies based on the experience of our management as leaders, chief executive officers and board members of international businesses; |
• | access to potential asset disposals and divisional carve outs that owners (both companies and families) may have otherwise been considering as initial public offering candidates; |
• | our ties with other prominent families (particularly, but not exclusively, based in Europe) and founder-run businesses, providing access to private businesses which need additional capital and could also benefit from a public listing partnered with two long-term anchor investors; |
• | the extensive relationships of our management, via their board or council memberships, with other prominent European executives and entrepreneurs, further widening the reach of their network; |
• | our founders’ experience investing either directly or indirectly via specific funds or their network in global venture capital and private equity opportunities should ensure access to the broadest possible breadth of deal flow via portfolio companies; |
• | the history of our founders in constructively collaborating with other stakeholders and partnering with other families, offering a clear point of differentiation versus trade buyers or private equity buyers when negotiating a business combination with a founder-owned business; |
• | the experience of our founders in public and private markets and relationships with large European and U.S. institutions, creating attractive opportunities for sellers seeking to grow their business, particularly European businesses which would not otherwise have access to U.S. capital markets or would not easily access capital to fulfil their growth potential; and |
• | the personal network and connections of our independent board members and advisory committee members who will provide additional sourcing capabilities. |
• | have a clear European focus; |
• | have an identifiable current and/or future nexus with the United States making them suitable for a NYSE listing; |
• | will benefit from a public currency and access to an additional form of capital, enhancing their ability to pursue accretive acquisitions, high-return capital projects, and/or strengthen their balance sheet; |
• | will leverage the extensive networks of our management, our founders and advisory committee members as well as the team’s operational, transactional, financial, managerial and investment experience; and |
• | will offer an attractive risk-adjusted return for our shareholders. |
• | Real Estate; |
• | Banking and Insurance, except Fintech companies; |
• | Natural Resources and Infrastructure, except renewable sources of energy companies; |
• | Biotech; and |
• | Pure Media, Publishing and Advertising, except new business model or Tech angle companies. |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then-outstanding (other than in a public offering); |
• | Any of our directors, officers or substantial security holder (as defined by the NYSE rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 1% or more (or 5% or more if the related party involved is classified as such solely because such person is a substantial security holder); or |
• | The issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a shareholder vote; |
• | the risk that the shareholders would fail to approve the proposed business combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
4 |
Note to Calabrese: to discuss whether these two risk factors are necessary |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
• | may significantly dilute the equity interest of investors in our initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers, including the impact of ongoing trade wars between the United States and foreign countries; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; and |
• | deterioration of political relations with the United States. |
(1) | pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company, |
(2) | provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and |
(3) | provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements. |
Name |
Age |
Position | ||
Nassef Sawiris | 61 | Chairman and Chief Executive Officer | ||
Johann Dumas | 42 | Chief Financial Officer | ||
Colin Hall | 51 | Director | ||
Brent Hoberman | 53 | Director | ||
Sophie Krishnan | 46 | Director | ||
Roberto Mignone | 50 | Director |
• | executive chairman of NNS S.à r.l.-SPF, the Luxembourg-based parent company of the NNS Group; |
• | chairman & chief executive officer of NNS Advisers Limited; |
• | executive chairman of NNS UK Investment S.à r.l.-SPF, the Luxembourg-based parent company of the NNS UK Group; |
• | executive chairman of OCI N.V., a leading nitrogen fertilizer & chemicals producer listed on the Euronext Amsterdam; |
• | member of the supervisory board of adidas, the leading European sportswear company; |
• | executive chairman of Aston Villa Football Club; |
6 |
Note to Company: please review and confirm if any updates are required (please review description of sponsors, bios of directors and officers) |
• | chief executive officer of Fertiglobe Holding Limited; |
• | director of Orascom Construction Industries S.A.E.; |
• | director of Firewater LLC; |
• | director of Middle East Petrochemical Corporation; |
• | director of OS Holding; |
• | director of NNS City; and |
• | member of the International Council of J P Morgan Chase Co, the Board of Trustees of the University of Chicago, the Cleveland Clinic’s International Leadership Board Executive Committee, the Council on Foreign Relations Global Board of Advisors and Exor Partners Council. |
• | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
• | monitoring the independence of the independent registered public accounting firm; |
• | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
• | inquiring and discussing with management our compliance with applicable laws and regulations; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of our initial public offering; and |
• | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. |
• | should have demonstrated notable or significant achievements in business, education or public service; |
• | should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
• | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer; |
• | reviewing and approving the compensation of all of our other Section 16 executive officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | directors should not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Nassef Sawiris | OCI N.V. (1) |
Nitrogen fertilizer and chemicals producer | Executive Chairman | |||
adidas AG | European sportswear company | Member of the Supervisory Board | ||||
NNS S.à r.l.-SPF (1) |
Parent company of the NNS Group | Executive Chairman | ||||
NNS Advisers Limited | Investment advisory company to the NNS Group and NNS UK Group | Chief Executive Officer / Chairman | ||||
Aston Villa Football Club | Professional British football club | Executive Chairman | ||||
NNS UK Investment S.à r.l.-SPF |
Parent company of the NNS UK Group | Executive Chairman | ||||
OS Holding | Private investment company | Director | ||||
NNS City | Private investment company | Director | ||||
Colin Hall | Groupe Bruxelles Lambert | Holding investment company | Investment Partner | |||
Sienna Capital | Holding investment company | Director / Vice Chairman | ||||
Imerys | Production and processing of industrial minerals | Director | ||||
GEA Group AG | Suppliers for food processing technology and of related industries | Director | ||||
Holcim Ltd | Global leader in building materials and solutions | Director | ||||
Ergon Capital Partners | Holding investment company | Director | ||||
Ergon Capital Partners II | Holding investment company | Director | ||||
Ergon Capital Partners III | Holding investment company | Director |
7 |
Note to Company: please review and confirm if any updates to the table are required |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Marnix French ParentCo | Customer management and business process outsourcing | Director | ||||
Globality Inc. | Smart sourcing platform for business services | Director | ||||
Johann Dumas | Sienna Capital Participations S.à r.l. | Holding investment company | Director | |||
Sienna Capital Coinvest Master S.à r.l. | Holding investment company | Director | ||||
Sienna Capital Opportunity GP S.à r.l. | Holding investment company | Director | ||||
SC Opportunity Master S.à r.l. | Holding investment company | Director | ||||
Sienna Capital Management S.A | Holding and investment management | Director | ||||
Sienna IM Digital GP S.à r.l. | Holding investment company | Director | ||||
Brent Hoberman | Founders Factory | Multi-sector accelerator and incubator | Co-Founder and Executive Chairman | |||
Firstminute Capital | Seed fund | Co-Founder and Executive Chairman | ||||
Founders Forum | Private network for digital and technology entrepreneurs | Co-Founder and Executive Chairman | ||||
Karakuri | Food and technology industry | Executive Chairman | ||||
Grip.events | Event networking solution | Co-Founder and Chairman | ||||
Roberto Mignone | Teva Pharmaceuticals | Pharmaceutical company | Director | |||
Bridger Management LLC (1) |
Investment fund | Founder and Managing Partner |
• | Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our Sponsor subscribed for founder shares prior to the date of our initial public offering and purchased private placement warrants in a transaction that closed simultaneously with the closing of our initial public offering. |
• | We entered into a forward purchase agreement with our Sponsor forward purchase agreement with the Sponsor, pursuant to which the Sponsor committed to purchase from the Company up to 10,000,000 forward purchase units, each consisting of one Class A ordinary share (“forward purchase share”) and one-half of one warrant to purchase one Class A ordinary share (“forward purchase warrant”), for $10.00 per unit, or an aggregate amount of up to $100,000,000, in a private placement that will close substantially concurrently with the closing of a Business Combination. |
• | Our Sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. Additionally, our Sponsor has agreed to waive its rights to liquidating distributions from the trust account with respect to its founder shares if we fail to complete our initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein, our Sponsor and our directors and executive officers have agreed not to transfer, assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business |
combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20-trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business combination. In case of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any agreement with respect to our initial business combination. In addition, our Sponsor, officers and directors may sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates. |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our executive officers and directors that beneficially owns ordinary shares; and |
• | all our executive officers and directors as a group. |
Class B ordinary shares |
Class A ordinary shares |
|
||||||||||||||||||
Name of Beneficial Owners(1) |
Number of Shares Beneficially Owned (2) |
Approximate Percentage of Class |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
Approximate Percentage of Voting Control |
|||||||||||||||
Avanti Acquisition SCSp (our Sponsor) (3) |
14,925,000 | (4) |
99.6 | % | — | — | 19.9 | % | ||||||||||||
Nassef Sawiris |
— | (5) |
— | — | — | — | ||||||||||||||
Colin Hall |
— | (5) |
— | — | — | — | ||||||||||||||
Johann Dumas |
— | (5) |
— | — | — | — | ||||||||||||||
Brent Hoberman |
25,000 | — | — | |||||||||||||||||
Sophie Krishnan |
25,000 | * | — | — | ||||||||||||||||
Roberto Mignone |
25,000 | * | 100,000 | (6) |
* | * | ||||||||||||||
All officers and directors as a group (six individuals) |
75,000 | * | — | — | ||||||||||||||||
Luxor Capital Partners, LP (7)(10) |
— | — | 2,953 | * | * | |||||||||||||||
Luxor Capital Partners Offshore Master Fund, LP (8)(10) |
— | — | 1,911 | * | * | |||||||||||||||
Lugard Road Capital Master Fund, LP (9)(10) |
— | — | 354,403 | * | * | |||||||||||||||
Falcon Edge Capital, LP (11) |
— | — | 7,170,000 | 11.9 | % | 9.6 | % | |||||||||||||
Citadel Advisors LLC (12) |
— | — | 2,011,902 | 3.4 | % | 2.7 | % | |||||||||||||
Baupost Group, L.L.C. (13) |
— | — | 4,000,000 | 6.7 | % | 5.3 | % | |||||||||||||
Vellar Opportunities Fund Master, Ltd. (14) |
— | — | 100,000 | * |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of our shareholders is PO Box 1093, Boundary Hall, Cricket Square, Grand Cayman, KY1-1102, Cayman Islands. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described in the section entitled “Description of Securities.” Excludes Class A ordinary shares issuable pursuant to the forward purchase agreement, as such shares will only be issued concurrently with the closing of our initial business combination. |
(3) | Represents 14,925,000 shares of Class B ordinary shares, $0.0001 par value per share, of the Issuer (the “Class B ordinary shares”) directly held by Avanti Acquisition SCSp. The Class B ordinary shares will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer (the “Class A ordinary shares”) at the time of the issuer’s initial business combination, or earlier at the option of the holder, on a one-for-one 333-248838 and 333-249241), filed in connection with the Issuer’s initial public offering.. |
(4) | Excludes up to 2,250,000 founder shares that were surrendered to us for no consideration by our Sponsor upon the expiry of the underwriters’ over-allotment option on November 20, 2020. |
(5) | Does not include any shares indirectly owned by this individual as a result of his membership interest in our Sponsor. |
(6) | Represents Class A Ordinary Shares held of record by Swiftcurrent Partners, L.P. and Swiftcurrent Offshore Master, Ltd. (the “Funds”). Bridger Management, LLC is the investment adviser to the Funds and Mr. Roberto Mignone is the manager of Bridger Management, LLC. |
(7) | Luxor Capital Partners, LP (the “Onshore Fund”) beneficially owns 2,953 Class A Ordinary Shares. |
(8) | Luxor Capital Partners Offshore Master Fund, LP (the “Offshore Master Fund”) beneficially owns 1,911 Class A Ordinary Shares. Luxor Capital Partners Offshore, Ltd. (the “Offshore Feeder Fund”) as the owner of a controlling interest in the Offshore Master Fund, may be deemed to have beneficially owned the Class A Ordinary Shares beneficially owned by the Offshore Master Fund. |
(9) | Lugard Road Capital Master Fund, LP (the “Lugard Master Fund”) beneficially owns 354,403 Class A Ordinary Shares. |
(10) | LCG Holdings LLC (“LCG Holdings”), as the general partner of the Onshore Fund, the Offshore Master Fund and Luxor Wavefront, LP (the “Wavefront Fund”) may be deemed to have beneficially owned the 4,864 Class A Ordinary Shares beneficially owned by the Onshore Fund, the Offshore Master Fund and the Wavefront Fund; Lugard Road Capital GP, LLC (“Lugard GP”), as the general partner of the Lugard Master Fund, may be deemed to have beneficially owned the 354,403 Class A Ordinary Shares beneficially owned by the Lugard Master Fund; Mr. Jonathan Green, as a managing member of Lugard GP, may be deemed to have beneficially owned the 354,403 Class A Ordinary Shares beneficially owned by Lugard GP; Luxor Capital Group, LP (“Luxor Capital Group”), as the investment manager of the Onshore Fund, the Offshore Feeder Fund, the Offshore Master Fund, the Lugard Master Fund and the Wavefront Fund (collectively, the “Funds”), may be deemed to have beneficially owned the 359,267 Class A Ordinary Shares beneficially owned by the Funds; Luxor Management, LLC (“Luxor Management”), as the general partner of Luxor Capital Group, may be deemed to have beneficially owned the 359,267 Class A Ordinary Shares beneficially owned by Luxor Capital Group; and Mr. Christian Leone, as the managing member of Luxor Management, may be deemed to have beneficially owned the 359,267 Class A Ordinary Shares beneficially owned by Luxor Management. The principal business address of each of the Onshore Fund, the Wavefront Fund, Luxor Capital Group, Luxor Management, Lugard GP, LCG Holdings, Mr. Green and Mr. Leone is 1114 Avenue of the Americas, 28 th Floor, New York, New York 10036. The principal business address of each of the Offshore Master Fund, the Offshore Feeder Fund and the Lugard Master Fund is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. |
(11) | Represents 7,170,000 Class A Ordinary Shares held by (i) Falcon Edge Capital, LP a Delaware limited partnership, and the investment manager of certain affiliated funds (the “Falcon Edge Funds”) held by the Falcon Edge Funds; and (ii) Mr. Richard Gerson who serves as the Chairman and Chief Investment Officer of the Investment Manager, with respect to the Class A Ordinary Shares held by the Falcon Edge Funds. The address of their business office is 660 Madison Avenue, 19 th Floor, New York, New York 10065. |
(12) | Citadel Advisors LLC (“Citadel Advisors”) is the portfolio manager for Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company (“CM”). Citadel Advisors Holdings LP (“CAH”) is the sole member of Citadel Advisors. Citadel GP LLC (“CGP”) is the general partner of CAH. Citadel Securities Group LP (“CALC4”) is the non-member manager of Citadel Securities LLC (“Citadel Securities”). Citadel Securities GP LLC (“CSGP”) is the general partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. Each of Citadel Advisors, CAH and CGP beneficially owns 1,768,532 Class A Ordinary Shares. Citadel Securities beneficially owns 243,370 Class A Ordinary Shares. Each of CALC4 and CSGP beneficially own 243,370 Class A Ordinary Shares. Mr. Griffin beneficially owns 2,011,902 Class A Ordinary Shares. The address of each of their principal business office is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603. |
(13) | Each of Baupost Group, L.L.C. (“Baupost”), Baupost Group GP, L.L.C. (“BG GP”) and Seth A. Klarman beneficially own 4,000,000 Class A Ordinary Shares. Securities reported on Schedule 13G as being beneficially owned by Baupost were purchased on behalf of certain of various private investment limited partnerships. The address of each of reporting persons’ principal business office is 10 St. James Avenue, Suite 1700 Boston, Massachusetts 02116. |
(14) | Represents 100,000 Class A Ordinary Shares held by (i) Vellar Opportunities Fund Master, Ltd.; (ii) Cohen & Company Financial Management, LLC; (iii) Dekania Investors, LLC; (iv) Cohen & Company LLC; (iv) Cohen & Company Inc.; and (v) Daniel G. Cohen. Mr. Cohen may be considered a control person for Cohen & Company Financial Management, LLC and Cohen & Company Inc. The address of the principal business office of Vellar Opportunities Fund Offshore, Ltd. is c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, PO Box 1348, Grand Cayman KY1-1108, Cayman Islands. The address of the principal business office of the other reporting entities / persons is 3 Columbus Circle, Suite 2400, New York, New York 10019, United States. |
* | Filed herewith |
** | Furnished herewith |
(1) | Incorporated by reference to the registrant’s Current Report on Form 8-K, filed with the SEC on October 06, 2020 |
AVANTI ACQUISITION CORP. |
/s/ Nassef Sawiris |
Name: Nassef Sawiris |
Title: Chairman and Chief Executive Officer |
Name |
Position |
Date | ||
/s/ Nassef Sawiris |
Chairman and Chief Executive Officer | March 31, 2022 | ||
Nassef Sawiris | (Principal Executive Officer) |
|||
/s/ Johann Dumas |
Chief Financial Officer | March 31, 2022 | ||
Johann Dumas | ( Principal Financial and Accounting Officer |
|||
/s/ Colin Hall |
Director | March 31, 2022 | ||
Colin Hall | ||||
/s/ Brent Hoberman |
Director | March 31, 2022 | ||
Brent Hoberman | ||||
/s/ Sophie Krishnan |
Director | March 31, 2022 | ||
Sophie Krishnan | ||||
/s/ Roberto Mignone |
Director | March 31, 2022 | ||
Roberto Mignone |
F-2 | ||
Financial Statements: |
||
F-3 | ||
F-4 | ||
F-5 | ||
F-6 | ||
F-7 to F-17 |
December 31, |
||||||||
2021 |
2020 |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Investments held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES, ORDINARY SHARES SUBJECT TO REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accounts payable and accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
Promissory note – related party |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
FPA liabilities |
||||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
TOTAL LIABILITIES |
||||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, |
||||||||
Shareholders’ Deficit |
||||||||
Preference shares, $ as of December 31, 2021 and 2020 |
||||||||
Class A ordinary shares, $ |
||||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO REDEMPTION AND SHAREHOLDERS’ DEFICIT |
$ |
$ |
||||||
|
|
|
|
Year Ended December 31, 2021 |
For the Period from July 24, 2020 (Inception) Through December 31, 2020 |
|||||||
Operating costs |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Other income (expenses): |
||||||||
Interest earned on investments held in Trust Account |
||||||||
Change in fair value of FPA liabilities |
( |
) | ||||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Loss on initial issuance of private warrants |
— | ( |
) | |||||
Transaction costs incurred in connection with IPO |
— | ( |
) | |||||
|
|
|
|
|||||
Total other income (expenses), net |
||||||||
|
|
|
|
|||||
Net income (loss) |
$ |
$ |
( |
) | ||||
|
|
|
|
|||||
Weighted average shares outstanding, Class A ordinary shares subject to possible redemption |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class A ordinary shares |
$ |
$ |
( |
) | ||||
|
|
|
|
|||||
Weighted average shares outstanding, Class B ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class B ordinary shares |
$ |
$ |
( |
) | ||||
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholder’s (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — July 24, 2020 (inception) |
— |
$ |
— |
$ | $ | $ | $ | |||||||||||||||||||||
Issuance of Class B ordinary shares to Sponsor (1) |
— | — | — | |||||||||||||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Forfeiture of Founder Shares |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — December 31, 2020 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — December 31, 2021 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
For the Period from July 24, 2020 (Inception) Through December 31, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Loss on initial issuance of private warrants |
||||||||
Change in fair value of FPA liability |
( |
) | ||||||
Transaction costs incurred in connection with IPO |
||||||||
Interest earned on investments held in Trust Account |
( |
) | ( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ||||||
Accounts payable and accrued expenses |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash into Trust Account |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
$ |
$ |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
$ | $ | ||||||
Proceeds from sale of Private Placements Warrants |
||||||||
Advances from - related party |
||||||||
Repayment of advances from related party |
( |
) | ||||||
Proceeds from promissory note - related party |
||||||||
Repayment of promissory note - related party |
( |
) | ||||||
Payment of offering costs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
$ |
$ |
||||||
|
|
|
|
|||||
Net Change in Cash |
$ |
( |
) |
$ |
||||
Cash – Beginning of period |
||||||||
|
|
|
|
|||||
Cash – End of period |
$ |
$ |
||||||
|
|
|
|
|||||
Non-Cash investing and financing activities: |
||||||||
Offering costs paid by Sponsor in exchange for issuance of founder shares |
$ | $ | ||||||
|
|
|
|
|||||
Offering costs paid through promissory note - related party |
$ | $ | ||||||
|
|
|
|
|||||
Payment of prepaid expenses through promissory note - related party |
$ | $ | ||||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | $ | ||||||
|
|
|
|
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A ordinary shares issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ |
|||
|
|
Year Ended December 31, 2021 |
For the Period from July 24, 2020 (Inception) Through December 31, 2020 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income (loss) per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income (loss), as adjusted |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares outstanding |
||||||||||||||||
Basic and diluted net income (loss) per ordinary share |
$ | $ | $ | ( |
) | $ | ( |
) |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the reported closing price of the Company’s Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ provided |
• | if, and only if, the last reported sale price (the “closing price”) of the Company’s Class A ordinary shares equals or exceeds $ |
• | if the closing price of the Class A ordinary shares for any |
Description |
Level |
December 31, 2021 |
December 31, 2020 |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
1 | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant Liabilities — Public Warrants |
1 | $ | $ | |||||||||
Warrant Liabilities — Private Placement Warrants |
2 | $ | $ | |||||||||
FPA Liability |
3 | $ | $ |
December 31, 2021 |
December 31, 2020 |
|||||||
Risk-free interest rate |
% | % | ||||||
Time to expiration, in Years |
||||||||
Unit price |
$ | $ | ||||||
Forward Price |
$ | $ |
FPA |
||||
Fair value as of July 24, 2020 (inception) |
$ | |||
Initial measurement on October 6, 2020 |
||||
Change in fair value |
||||
|
|
|||
Fair value as of December 31, 2020 |
$ | |||
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of December 31, 2021 |
$ | |||
|
|